Design of a Standardized Patient: Mentoring Program for Kidney Transplant Patients

Not Applicable

Brief Summary: There is an increasing number in patient's undergoing kidney transplantation in the United States. Furthermore, kidney recipients have high occurrence of 30-day readmissions that leads to high hospital costs and decreased quality of life for transplant recipients. A previous research finds that high levels of post-transplant anxiety is correlated with increased likelihood of 30-day readmissions. The goal of this study is to design and implementat a randomized control trial (RCT) using a standardized post-transplant mentoring program in order to reduce 30-day readmission and post-transplant anxiety among recipients.

Detailed Description: In this research, the investigators will seek to examine the efficacy of using former patients as mentors to newly transplanted patients and its relationship with patient anxiety following discharge as well as the prevention of 30-day readmissions for kidney transplant recipients. The primary hypothesis is that the treatment group of patients who undergo a targeted mentorship program will be better compliant with the discharge instructions and will perform better when compared to the control group who undergoes current routine post-transplantation care. Evidence from this experiment can help advance our understanding of patient-engagement in the continuity of care delivery, decrease patient readmission rates, and improve overall cost utilization.

Methods:

The investigators will conduct a single institution randomized control trial assigning patients getting discharged after a kidney transplant to a treatment group that involves a 30-day mentoring initiative by former transplant patients, and comparing the efficacy with a similar control group. The overall study period will be divided into the following sections, summarized in Figure 1.

Recruitment & Eligibility

Inclusion Criteria

any patient who received a kidney transplantation, deceased or living donor, during the study period.

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
Treatment Arm	Discharge Mentoring	Patients assigned to treatment arm will receive standard post-transplantation discharge care that includes weekly follow-up visits and 24-hour access to transplant triage call center. In addition, they will be matched with a mentor who will conduct 5 meetings with the patients (which includes one video chat meeting, 4 30-minute phone calls) and discuss the following topics related to post-discharge: Medications, Lab Work, Fluid Intake and Adherence to doctor's appointment

Primary Outcome Measures

Name	Time	Method
30-day readmissions	30-days

Secondary Outcome Measures

Name	Time	Method
Post Transplant Anxiety	1 Day of Discharge and 30-days after discharge	State-Trait Anxiety Inventory (STAI) for Adults
Preventable Re-admissions	30-days after day of discharge	Re admissions due to missed labs or medications as measured by time of readmission for any readmission that was deemed preventable by physiologic laboratory data, reason for readmission, and primary complaint determined by trained kidney transplantation nurses

Locations (1): Comprehensive Transplant Center
🇺🇸
Columbus, Ohio, United States

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial